journal article·2016-08-17

Nanotechnological approaches for the effective management of psoriasis

Tarun Garg, Goutam Rath, Amit K. Goyal

Publisher page

Abstract

Psoriasis is a chronic disorder with erythematous scaly patches, which typically affects the exposed surfaces of the body and scalp. Various factors such as bacterial infection, genetic and environmental factors, and immune disorders play an important role in causing psoriasis. Different types of psoriasis can be observed, such as guttate psoriasis, inverse psoriasis, pustular psoriasis, and psoriatic arthritis. Various ancient, topical, and systemic approaches have been used to control the disease, but have failed to achieve a complete reduction of the disease, besides causing toxic effects. Therefore, our main aim in this review article is to introduce the different advanced nanotechnological approaches for effective treatment of psoriasis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Psoriasis: Treatment and Pathogenesis · Advancements in Transdermal Drug Delivery · Retinoids in leukemia and cellular processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India

References (100+)

Show source-provided references
1. 10.1016/j.ijpharm.2015.03.02010.1016/j.ijpharm.2015.03.020 ↗
2. 10.3109/21691401.2013.83268310.3109/21691401.2013.832683 ↗
3. 10.3109/1061186X.2013.77177810.3109/1061186X.2013.771778 ↗
4. Ali MF · Med Sci Monit · 2008 · 14 · I66
5. 10.1159/00034360710.1159/000343607 ↗
6. 10.3109/1061186090307945410.3109/10611860903079454 ↗
7. Bhalaria MK · Indian J Exp Biol · 2009 · 47 · 368
8. 10.3109/08982104.2013.84319210.3109/08982104.2013.843192 ↗
9. 10.1016/j.ijpharm.2015.02.07010.1016/j.ijpharm.2015.02.070 ↗
10. 10.3109/1061186X.2014.95066410.3109/1061186X.2014.950664 ↗
11. Chaudhary S · Artif Cells Nanomed Biotechnol · 2015 · 1
12. 10.3390/ijms15081362410.3390/ijms150813624 ↗
13. 10.4155/fmc.12.17910.4155/fmc.12.179 ↗
14. 10.2147/CEOR.S3504610.2147/CEOR.S35046 ↗
15. Del Rosso JQ · J Clin Aesthet Dermatol · 2012 · 5 · 20
16. 10.1016/j.jaad.2003.09.01810.1016/j.jaad.2003.09.018 ↗
17. 10.1016/j.ejpb.2009.07.01110.1016/j.ejpb.2009.07.011 ↗
18. 10.1590/S0365-0596201200060000910.1590/S0365-05962012000600009 ↗
19. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
20. Garg T · Artif Cells Nanomed Biotechnol · 2014 · 1
21. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
22. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
23. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
24. 10.2174/221030310399913121111041410.2174/2210303103999131211110414 ↗
25. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
26. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
27. Garg T · Curr Drug Deliv · 2015
28. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
29. 10.3109/1061186X.2014.99289910.3109/1061186X.2014.992899 ↗
30. Garg T · Drug Deliv · 2014
31. Garg T · Artif Cells Nanomed Biotechnol · 2015 · 1
32. Garg T · Int J Pharm Sci Rev Res · 2011 · 7 · 211
33. Garg T · J Pharm Res · 2011 · 4 · 2097
34. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
35. 10.1016/j.micron.2007.06.01510.1016/j.micron.2007.06.015 ↗
36. 10.1016/j.clindermatol.2011.11.00110.1016/j.clindermatol.2011.11.001 ↗
37. 10.1007/978-3-662-45775-7_410.1007/978-3-662-45775-7_4 ↗
38. Goyal G · Drug Deliv · 2013
39. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
40. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
41. Gupta R · Artif Cells Nanomed Biotechnol · 2014 · 1
42. Hawilo A · Tunis Med · 2011 · 89 · 841
43. 10.4103/0378-6323.5774310.4103/0378-6323.57743 ↗
44. Henley ND · Guttate psoriasis. Am Fam Physician · 2012 · 86 · 361
45. 10.1166/jbt.2014.121410.1166/jbt.2014.1214 ↗
46. 10.2174/15672010677773111810.2174/156720106777731118 ↗
47. Johal HS · Drug Deliv · 2014 · 1
48. Joshi D · Drug Deliv · 2014 · 1
49. Joshi D · Curr Drug Deliv · 2014
50. Kalia V · Artif Cells Nanomed Biotechnol · 2014 · 1
51. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
52. 10.1248/yakushi.132.20110.1248/yakushi.132.201 ↗
53. Kaur G · Drug Deliv · 2015 · 1
54. Kaur M · Artif Cells Nanomed Biotechnol · 2014 · 1
55. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
56. Kaur M · Drug Deliv · 2014
57. Kaur N · Drug Deliv · 2014 · 1
58. Kaur P · Artif Cells Nanomed Biotechnol · 2015 · 1
59. Kaur P · Drug Deliv · 2014 · 1
60. Kaur P · Drug Deliv · 2014 · 1
61. Kaur P · J Drug Target · 2014 · 1
62. Kaur R · Artif Cells Nanomed Biotechnol · 2014 · 1
63. Kaur R · Drug Deliv · 2014 · 1
64. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
65. Kaur V · J Drug Target · 2014 · 1
66. 10.1016/j.ejpb.2012.04.00510.1016/j.ejpb.2012.04.005 ↗
67. 10.1016/j.ejps.2015.01.01210.1016/j.ejps.2015.01.012 ↗
68. 10.4103/0378-6323.3270910.4103/0378-6323.32709 ↗
69. Lee S · Rockville (MD) · 2012
70. 10.1007/s11095-011-0515-510.1007/s11095-011-0515-5 ↗
71. 10.1615/CritRevTherDrugCarrierSyst.201300791410.1615/CritRevTherDrugCarrierSyst.2013007914 ↗
72. 10.3109/1061186X.2014.96571510.3109/1061186X.2014.965715 ↗
73. 10.1016/j.jconrel.2012.09.01810.1016/j.jconrel.2012.09.018 ↗
74. Marwah H · Drug Deliv · 2014 · 1
75. Mease P · Bull NYU Hosp Jt Dis · 2012 · 70 · 167
76. Miroddi M · Phytother Res · 2015
77. Modgill V · Artif Cells Nanomed Biotechnol · 2014 · 1
78. Modgill V · Curr Drug Deliv · 2014
79. Morie A · Artif Cells Nanomed Biotechnol · 2014 · 1
80. Pabreja S · Artif Cells Nanomed Biotechnol · 2014 · 1
81. 10.3109/09546634.2011.59487110.3109/09546634.2011.594871 ↗
82. 10.4103/0975-7406.9414010.4103/0975-7406.94140 ↗
83. Patel T · Cutis · 2011 · 88 · 149
84. 10.1016/j.clindermatol.2011.11.00610.1016/j.clindermatol.2011.11.006 ↗
85. Pradhan M · Artif Cells Nanomed Biotechnol · 2014 · 1
86. 10.4103/2231-4040.8552410.4103/2231-4040.85524 ↗
87. Rohilla R · Drug Deliv · 2014 · 1
88. Rohilla R · Drug Deliv · 2014 · 1
89. 10.2174/15672010577437026710.2174/156720105774370267 ↗
90. Sharma A · Artif Cells Nanomed Biotechnol · 2014 · 1
91. Sharma AK · Artif Cells Nanomed Biotechnol · 2015 · 1
92. Sharma R · Artif Cells Nanomed Biotechnol · 2014 · 1
93. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
94. Singh B · Artif Cells Nanomed Biotechnol · 2014 · 1
95. Singh H · Artif Cells Nanomed Biotechnol · 2014
96. Singh K · Am J Pharm Tech Res · 2012 · 2 · 113
97. Singh K · Int J Institut Pharm life sci · 2012 · 2 · 58
98. Singh O · J Pharmaceutics · 2014 · 1
99. 10.1016/j.ijpharm.2012.01.04510.1016/j.ijpharm.2012.01.045 ↗
100. 10.2165/11532060-000000000-0000010.2165/11532060-000000000-00000 ↗